Revenue (Tables)

3 Months Ended

Dec. 25, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:    

		Three Months Ended December 25, 2021
Business (in millions)		United States		International		Total
Diagnostics:
	Cytology & Perinatal	$	80.9	$	49.8	$	130.7
	Molecular Diagnostics	528.0		285.3		813.3
	Blood Screening	6.4		—		6.4
Total		$	615.3	$	335.1	$	950.4
Breast Health:
	Breast Imaging	$	208.9	$	73.4	$	282.3
	Interventional Breast Solutions	62.1		14.9		77.0
Total		$	271.0	$	88.3	$	359.3
GYN Surgical		$	109.3	$	25.0	$	134.3
Skeletal Health		$	16.8	$	10.3	$	27.1
		$	1,012.4	$	458.7	$	1,471.1

		Three Months Ended December 26, 2020
Business (in millions)		United States		International		Total
Diagnostics:
	Cytology & Perinatal	$	80.1	$	44.7	$	124.8
	Molecular Diagnostics	675.3		320.0		995.3
	Blood Screening	8.1		—		8.1
Total		$	763.5	$	364.7	$	1,128.2
Breast Health:
	Breast Imaging	$	203.0	$	64.7	$	267.7
	Interventional Breast Solutions	55.2		9.8		65.0
Total		$	258.2	$	74.5	$	332.7
GYN Surgical		$	101.0	$	23.0	$	124.0
Skeletal Health		$	15.1	$	9.8	$	24.9
		$	1,137.8	$	472.0	$	1,609.8

	Three Months Ended
Geographic Regions (in millions)	December 25, 2021		December 26, 2020
United States	$	1,012.4	$	1,137.8
Europe	295.1		338.2
Asia-Pacific	119.7		88.3
Rest of World	43.9		45.5
	$	1,471.1	$	1,609.8

The following table provides revenue recognized by source:

	Three Months Ended
Revenue by type (in millions)	December 25, 2021		December 26, 2020
Disposables	$	1,106.3	$	1,263.4
Capital equipment, components and software	197.0		192.0
Service	162.8		137.1
Other	5.0		17.3
	$	1,471.1	$	1,609.8